Injured Agraquest Biotech Worker David Bell Tells His Story

*INJURED AGRAQUEST BIOTECH WORKER DAVID BELL TELLS HIS STORY"
TRANSCRIPTION WITH SUPPORTING DOCUMENTATION:
http://www.biotechawareness.com/index~option~com_content~view~article~id~174.php

On 12/12/2008 Labor On The Job interviewer, Steve Zeltzer interviewed Agraquest biotech worker David Bell. David talks about his work at the Davis, California based biotechnology company Agraquest, owned by the former Monsanto scientist and former NovoNordisk Entotech owner, Pam Marrone.

This video is just a small fraction of what happens to employees working in the biotechnology field. More and more evidence is emerging that this industry in not as safe as we are being led to believe.

Moreover, this industry is not being held accountable for the injuries, illnesses, diseases, maimings and even death that befalls their employees; biotech companies merely claim, “Trade Secrets” in denying the injured worker his or her constitutional rights to know what he or she has been exposed to in the workplace environment.

David Bell discusses among other things:
•How the lack of proper health and safety protection led to his contamination from bacteria and fungus at Agraquest.
•His sickness after he was only with the company for 5 months and 9 days and the horror that has followed; 4 major sinus surgeries, loss of an intact immune system, and the continual infections he has had to endure over the years.
•How Agraquest did, and still is covering-up their responsibility for his illnesses and diseases.
•The corruption and the breakdown within the California workers compensation system.
•The failure of health and safety regulatory agencies; such as the EPA and OSHA to regulate the biotechnology industry.

http://www.biotechawareness.com/index~option~com_content~view~article~id~174.php
..............................
ADDITIONALLY, Becky McClain, injured molecular biologist from Connecticut spoke of the dangers in working in the biotechnology industry during the 2009 Workers Memorial Day event in San Francisco.

Mrs. McClain also encountered the same plight as David Bell; NOT KNOWING what she had been exposed to THAT MADE HER SICK ( industry's "TRADE SECRETS"), non-compliance of: the Occupational Safety and Health Administration, agencies within the state of Connecticut, including U.S. Federal Agencies.

VIEW THIS VIDEO http://blip.tv/file/2061380

The following bacteria and fungi have been identified in David Bell's cultures of his sinuses, sputum, nose and/or tested from positive to HIGH POSITIVE in IgG MAST tests. ALL of these microorganisms are related to his occupational exposure at Agraquest in Davis, California.

4+Acinetobater - Sourse Sinus
Acremonium species - Source Sputum
Curvularia - Source Sinus
Penicillium - Source Sputum + HIGH POSITIVE IgG MAST testing
Pseudomonas - Source Numerous
Staph - Source Numerous
Rare mucus - Source Urinalysis
Histoplasma - Source Blood Serum
Alternaria - Source POSITIVE IgG MAST testing
Aspergillus - Source POSITIVE IgG MAST testing
Botrytis - Source POSITIVE
Cladosporium -Source HIGH POSITIVE IgG MAST testing
Eppicoccum - Source POSITIVE IgG MAST testing
Fusarium - Source HIGH POSITIVE IgG MAST testing
Helminthosporium - Source HIGH POSITIVE IgG MAST testing
Mucor - Source POSITIVE IgG MAST testing
Pullularia - Source POSITIVE IgG MAST testing
Rhizopus - Source POSITIVE IgG MAST testing
Stemphylium - Source POSITIVE IgG MAST testing

To view the list and see the Agraquest Connections please see CROSS-OVER INFECTIONS FROM BIOLAB
http://www.docstoc.com/docs/21733928/CROSS-OVER-INFECTIONS-FROM-BIOLAB


The fungus; histoplasma capsulateum; which causes the human disease histoplasmosis, was identified in David Bell's blood serum by the Mayo Clinic laboratory in Rochester, Minnesota.

Although Agraquest denied any and all connections to histoplasma being related to David Bell's employment with the company; it was discovered that four (4) days after David Bell became ill on January 18, 1999, the Agraquest scientists on Pam Marrone's United States Patent 6,004,774 began signing away their interest rights on this patent. The patent states, "Additionally, an antifungal composition comprising an extract produced by B. subtilis strain ATCC 55614 may be used to treat human fungal diseases in which the disseminated disease propagule is a conidia, for example, Aspergillus sp., HISTOPLASMA sp., and Tinea sp."
Documents are provided below (all images enlarge):

HISTOPLASMA & DAVID BELL's MEDICAL RELATED TO AGRAQUEST WORKPLACE/LAB
http://www.biotechawareness.com/index~option~com_content~view~article~id~239.php